Sangamo Therapeutics
SGMO
#9340
Rank
ยฃ78.94 M
Marketcap
ยฃ0.19
Share price
-4.66%
Change (1 day)
-65.82%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -ยฃ83.1 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ32.87 Million. In 2024 the company made an earning of -ยฃ72.87 Million, an increase over its 2023 earnings that were of -ยฃ88.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ83.1 Million14.04%
2024 -ยฃ72.87 Million-17.27%
2023 -ยฃ88.07 Million-40.88%
2022 -ยฃ0.15 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ95.88 Million23.17%
2019 -ยฃ77.85 Million36.33%
2018 -ยฃ57.1 Million36.89%
2017 -ยฃ41.72 Million-22.32%
2016 -ยฃ53.7 Million54.86%
2015 -ยฃ34.68 Million75.62%
2014 -ยฃ19.75 Million0.13%
2013 -ยฃ19.73 Million
2011 -ยฃ26.52 Million43.66%
2010 -ยฃ18.46 Million28.52%
2009 -ยฃ14.36 Million-23.55%
2008 -ยฃ18.79 Million2.45%
2007 -ยฃ18.34 Million19.5%
2006 -ยฃ15.35 Million50.78%
2005 -ยฃ10.18 Million75%
2004 -ยฃ5.82 Million-33.25%
2003 -ยฃ8.72 Million-62.27%
2002 -ยฃ23.09 Million102.82%
2001 -ยฃ11.39 Million23.21%
2000 -ยฃ9.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.83 B-30,874.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.64 B-8,332.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.15 B-1,527.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ1.86 Billion 2,203.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.25 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ16.59 B-20,666.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.42 B-628.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.35 B-542.54%๐Ÿ‡บ๐Ÿ‡ธ USA